Bristol Myers Squibb Co. (BMY)
Bristol Myers Squibb Market Cap: 112.50B for Jan. 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 177.92B |
| Gilead Sciences, Inc. | 154.97B |
| Johnson & Johnson | 526.82B |
| Eli Lilly & Co. | 929.39B |
| Regeneron Pharmaceuticals, Inc. | 77.04B |
Market Cap Related Metrics
| PE Ratio | 18.66 |
| PS Ratio | 2.345 |
| Price to Book Value | 6.064 |
| Price to Free Cash Flow | 7.362 |
| Price | 55.26 |
| Earnings Yield | 5.36% |
| Operating PE Ratio | 8.038 |
| Normalized PE Ratio | 10.51 |